Emily Naugle joins Morning Light today, talking about the FDAs recent approval of a new generic abortion drug and the safety data study from an April review showing the complication rate. Learn more at the following links:
https://www.lifesitenews.com/news/breaking-trumps-fda-approves-new-generic-abortion-pills-despite-pro-life-promises/?utm_source=digest-prolife-2025-10-02&utm_medium=email
https://www.liveaction.org/news/study-nearly-11-serious-adverse-abortion-pill